...
首页> 外文期刊>Gynecologic Oncology: An International Journal >Surgical treatment of “intermediate risk” lymph node negative cervical cancer patients without adjuvant radiotherapy—A retrospective cohort study and review of the literature
【24h】

Surgical treatment of “intermediate risk” lymph node negative cervical cancer patients without adjuvant radiotherapy—A retrospective cohort study and review of the literature

机译:手术治疗“中间风险”淋巴结阴性宫颈癌患者没有辅助放射治疗 - 一种回顾性队列研究与文献综述

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

ObjectivesThe role of adjuvant radiotherapy for lymph node-negative stage IB patients with tumor-related negative prognostic factors is not uniformly accepted. It is advocated based on the GOG 92 trial, which was initiated in 1989. The aim of the current study is to report the oncological outcome of “intermediate risk” patients treated by tailored surgery without adjuvant radiotherapy. Data from two institutions that refer these patients for adjuvant radiotherapy served as a control group. MethodsIncluded were patients with stage IB cervical cancer treated with radical hysterectomy and pelvic lymphadenectomy, who had negative pelvic lymph nodes but a combination of negative prognostic factors adopted from the GOG 92 trial. Data were obtained from prospectively collected databases of three institutions. Radical surgery was a single-treatment modality in one of them and in the remaining two institutes it was followed by adjuvant chemoradiation. ResultsIn 127 patients who received only radical surgery, with a median follow-up of 6.1?years, the local recurrence rate was 1.6% (2 cases), and total recurrence was 6.3% (8 cases). Disease-specific survival at 5?years was 95.7% (91.9%; 99.4%) and 91% (83.7%; 98.3%) at 10?years. The only significant factor for disease-specific survival was tumor size ≥4?cm (P?=?0.032). The recurrence rate, local control or overall survival did not differ from the control group. Adjuvant radiotherapy was not a significant prognostic factor within the whole cohort. ConclusionsAn excellent oncological outcome, especially local control, can be achieved by both radical surgery or combined treatment in stage IB lymph node-negative cervical cancer patients with negative prognostic factors. The substantially better outcome than in the GOG 92 trial can be attributed to more accurate pre-operative and pathological staging and an improvement in surgical techniques.
机译:辅助放疗对淋巴结阴性阶段IB患者的辅助放射疗法的客观作用并不均匀地接受肿瘤相关的负预后因素。基于GOG 92审判,它是在1989年开始的GOG 92审判的倡导。目前的研究的目的是报告在没有佐剂放射治疗的量身定制手术治疗的“中间风险”患者的肿瘤政治结果。来自两个院校的数据,将这些患者提供佐剂放射疗法作为对照组。 Metha方法是用自由基子宫切除术和盆腔淋巴结切除术治疗的阶段IB宫颈癌患者,患有负盆腔淋巴结,但GOG 92试验中采用的负预后因素的组合。数据是从预计的三个机构的预期收集的数据库获得。激进的手术是其中一个的单一治疗方式,并且在其余的两个研究所中,它之后是佐剂校长。结果127患者只接受激进的手术,中位随访6.1?多年来,局部复发率为1.6%(2例),总复发为6.3%(8例)。 5岁的疾病特异性存活率为95.7%(91.9%; 99.4%)和91%(83.7%; 98.3%),10年满。疾病特异性存活的唯一重要因素是肿瘤大小≥4?cm(p?= 0.032)。复发率,局部控制或整体存活与对照组没有不同。佐剂放射疗法不是整个队列内的显着预后因素。结论an优异的肿瘤政治结果,尤其是局部对照,可以通过阶段IB淋巴结阴性宫颈癌患者的自由基手术或组合治疗来实现,负预后因素。比GOG 92试验的结果基本上更好的结果可以归因于更准确的术前和病理分期和手术技术的改善。

著录项

  • 来源
  • 作者单位

    Charles University in Prague and General University Hospital in Prague;

    Gynecology Service Department of Surgery Department of Radiation Oncology Memorial Sloan;

    Charles University in Prague and General University Hospital in Prague;

    Chris O'Brien Comprehensive Cancer Centre University of Sydney;

    Gynecology Service Department of Surgery Department of Radiation Oncology Memorial Sloan;

    Charles University in Prague and General University Hospital in Prague;

    Gynecology Service Department of Surgery Department of Radiation Oncology Memorial Sloan;

    Department of Radiation Oncology and Cancer Imaging Peter MacCallum Cancer Centre Department of;

    Charles University in Prague and General University Hospital in Prague;

    Charles University in Prague and General University Hospital in Prague;

    Charles University in Prague and General University Hospital in Prague;

    Charles University in Prague and General University Hospital in Prague;

    Institute for Biostatistics and Analyses Faculty of Medicine Masaryk University;

    Department of Radiation Oncology and Cancer Imaging Peter MacCallum Cancer Centre Department of;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号